Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: a meta-analysis.
<h4>Background</h4>Chronic hepatitis C virus (HCV) infection is one of the leading causes of hepatic cirrhosis and hepatocellular carcinoma, and HCV genotype 1 is the most prevalent genotype and is resistant to current standard therapy. We performed this meta-analysis to evaluate the eff...
Guardado en:
Autores principales: | Yuan Kong, Xiaoping Wang, Yushu Shang, Paul M Schroder, Wenhua Liang, Xiaoting Ling, Zhiyong Guo, Xiaoshun He |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9bb02f5ccd264deb9697c71e82c55b96 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials.
por: Tara L Kieffer, et al.
Publicado: (2012) -
Treatment of experienced and na&iuml;ve patients with hepatitis C: focus on telaprevir
por: D&#39;Ambrosio R, et al.
Publicado: (2012) -
Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.
por: Xiwei Wang, et al.
Publicado: (2014) -
Controlador de élite curado del virus de hepatitis C tras 14 semanas de triple terapia basada en telaprevir
por: Pérez,Diego, et al.
Publicado: (2015) -
Comparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysis.
por: Weixia Ke, et al.
Publicado: (2014)